Macquarie lifted price target to $36.25 from $35.40 & retained Outperform.
- Forums
- ASX - By Stock
- Ann: ResMed Announces Results for the Fourth Quarter of FY2024
Macquarie lifted price target to $36.25 from $35.40 & retained...
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
$35.72 |
Change
0.120(0.34%) |
Mkt cap ! $22.96B |
Open | High | Low | Value | Volume |
$35.72 | $35.97 | $35.58 | $71.16M | 1.992M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3387 | $35.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$35.75 | 3028 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 561 | 35.620 |
1 | 28 | 35.180 |
1 | 1000 | 35.000 |
1 | 1300 | 34.800 |
1 | 177 | 34.610 |
Price($) | Vol. | No. |
---|---|---|
35.750 | 5 | 1 |
35.840 | 2392 | 1 |
35.850 | 2500 | 1 |
35.900 | 1130 | 3 |
35.950 | 1938 | 2 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online